Diabetic nephropathy (DN) is one of the serious microvascular complications of diabetes mellitus and is the main cause of end-stage renal failure around the world^[@r1],[@r2],[@r3]^. Its symptoms appear around 10 years after the onset of diabetes mellitus. Many treatments have been tried, but no fundamental treatment has yet been found. Not only better treatments but also preventive methods are urgently needed worldwide. Therefore, full understanding of the development and progression of DN is a prerequisite.

Animal models are powerful tools for understanding pathogenetic mechanisms. Models used in current DN research partially show the pathological changes of human DN and contribute to understanding the pathological characteristics^[@r4]^. However, the models fail to show the structural features of advanced human disease because most have been developed in different ways, surgically, pharmacologically, and/or genetically modified, from the actual process in humans^[@r5],[@r6]^, although diabetic complications progress as pathogenic lesions with increasing age. There are few animals suitable for elucidating the progressive pathological changes that occur with increasing age.

The kidney is one of the controllers of fluid homeostasis^[@r7]^. Diabetes mellitus, hypertrophy, albuminuria, and other factors damage the kidney and result in progressive nephropathy in humans^[@r8],[@r9]^. Among animal models showing DN, streptozotocin-induced rodents, high-fat diet-induced mice, Ins2 Akita mice, NOD mice, *db*/*db* mice, and New Zealand obesity mice have been frequently used^[@r5]^. They show some of the characteristic lesions of humans with DN. Although the ZDF rat and the *cp*/*cp* rat are also animals with leptin-receptor deficiency and exhibit hyperglycemia, some of these rats do not always show hyperglycemia, and in others, glucose tolerance improves with aging^[@r10]^, due to the high ability of their islet beta-cells to secrete insulin, which is an innate characteristic of rats^[@r11]^. To use rats as a model of DN, rats that are congenitally hypertensive^[@r10]^ or have undergone transgenic modification must be used^[@r12]^. Since there are also various differences in metabolism and compensatory functions among mouse strains, they show different characteristics of DN^[@r5]^. Therefore, researchers have carefully taken their characteristics into account and effectively used model animals to extrapolate the findings to humans.

The medaka kidney is well characterized and is anatomically and functionally similar to human and rodent kidneys^[@r13]^. Genetic approaches, the method of targeting induced local lesions in the genome (TILLING)^[@r14]^, targeted mutagenesis using transcription activator-like effector nucleases (TALENs)^[@r15]^, and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (CAS) system^[@r16]^ have been successful, and rearing conditions have been established experimentally^[@r17]^. These approaches make it possible to analyze various phenotypes at the laboratory level. It has been expected that medaka would be used in the development of human disease models that display pathological changes of human disease, along with other experimental animals.

Leptin is a peptide hormone secreted by adipose tissue in mammals and by the liver in fish^[@r18],[@r19],[@r20]^. It has been shown to play a key role in the maintenance of energy homeostasis through the regulation of food intake, glucose metabolism, and a range of physiological functions^[@r21],[@r22]^. Leptin- or leptin receptor-deficient rats and mice spontaneously develop hyperphagia, which leads to obesity, and they display several type II diabetes mellitus-like characteristics^[@r23],[@r24]^. In the case of small fish research, Alvarez *et al*. induced thinning of the retina in zebrafish to a slight degree by immersion in glucose solution^[@r25]^. The fish showed no significant changes in other tissues. Some researchers also used zebrafish and induced hyperglycemia by the artificial manipulation of genes. Adult fish with hyperglycemia showed pathological changes in the retina, but not in the kidneys^[@r26],[@r27]^.

Previously, we succeeded in producing medaka that were homozygous for leptin receptor gene mutation \[leptin receptor-deficient (LRD) medaka\] by the TILLING method^[@r28]^. Furthermore, we demonstrated that LRD medaka showed hyperglycemia and hypoinsulinemia, resulting in histopathological changes of eyeballs that were similar to the histopathologic characteristics in the ocular lesions of diabetic cataract and retinopathy in rodents^[@r29],[@r30]^. The retinopathy in medaka was induced noninvasively only by increased feeding. The pathological changes were mainly caused by microvascular changes in the retina. Therefore, we presumed that our rearing method would also lead to characteristics in LRD medaka kidneys equivalent to the histopathologic ones in rodents with DN.

The purpose of the present study was to clarify the histopathologic characteristics of the lesions of LRD medaka equivalent to those in DN in humans and rodent models and to evaluate the usefulness of the LRD medaka as a model of DN. This will contribute to the development of a novel diabetic model with structural features of advanced human disease.

In the present study, CAB/KYOTO-substrain medaka (*Oryzias latipes*) were used as the wild type strain (control medaka). Medaka with a homozygous leptin receptor gene mutation (LRD medaka) were produced by the TILLING method as described previously^[@r28]^. Fish were maintained at 25 to 26°C with a 14:10 h (light:dark) cycle in a recirculating aquaculture system equipped with carbon filtration and biofiltration. They were fed a standard feed for freshwater fish (particle size \<0.25 mm and \<0.36 mm, protein \>50.0%, fat \>10.0%, fiber \<3.0%, ash \<16.0%, Ca \>2.00%, phosphate \>1.50%; Otohime A and B1, Marubeni Nissin Feed Co., Ltd., Tokyo, Japan). The experiment was performed following the guidelines of the Animal Research Committee of Kyorin University (approval number 218 in 2018).

Fish were weighed, and their kidneys were examined histopathologically (n=6, 6, and 11 at 10, 20, and 30 weeks of age, respectively). All sampling was conducted to have an almost equal sex ratio. The sampling schedule was designed to obtain LRD medaka with normal and abnormal blood glucose levels. LRD medaka show hyperglycemia at 12--15 weeks of age and over. Fish were euthanized using 0.003% eugenol (FA100, Tanabe Seiyaku Co., Ltd., Osaka, Japan), and blood was collected from the main artery and vein. The fasting plasma glucose levels were measured using a portable glucose meter (Nipro CareFast Meter and test stripes, Nipro, Tokyo, Japan; n=6 and 6 at 20 and 30 weeks of age, respectively). The postprandial plasma insulin levels were measured by a method described previously^[@r31]^ (n=6 and 6 at 20 and 30 weeks of age, respectively). The creatinine levels in the blood were measured using a LabAssay^TM^ Creatinine Kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan; n=6 and 6 at 20 and 30 weeks of age, respectively). The fish were then fixed *in toto* in Bouin's fluid overnight before postfixation with 10% neutral buffered formalin, embedded in paraffin, cut into sagittal sections, and routinely stained with hematoxylin-eosin.

All values are expressed as means ± standard error (SE). Comparisons of differences between the control medaka and the LRD medaka were analyzed using Excel Toukei 2015 statistical software (SSRI Co., Ltd., Tokyo, Japan). The data from the two groups were analyzed using the *F*-test. When variances were homogeneous, Student's *t*-test was used. Welch's *t*-test was used when variances were not homogeneous. *P* values of \<0.01 were considered significant.

The body weights of the LRD medaka were higher than those of the control medaka ([Table 1](#tbl_001){ref-type="table"}Table 1.Body Weight). Although fasting blood glucose levels tended to be relatively high in LRD medaka at 10 weeks of age, there was no significant difference between control and LRD medaka. At 20 and 30 weeks of age, LRD medaka demonstrated hyperglycemia ([Table 2](#tbl_002){ref-type="table"}Table 2.Fasting Blood Glucose Level). Plasma insulin levels in LRD medaka at 20 and 30 weeks of age were significantly lower than those in control medaka ([Table 3](#tbl_003){ref-type="table"}Table 3.Postprandial Plasma Insulin Level). Our most recent research indicates that hypoinsulinemia in LRD medaka would be caused by changes in gene expressions involved in insulin secretion, not a decrease in the number of beta cells and/or their death by apoptosis (unpublished data). This suggested that LRD medaka developed hyperglycemia and hypoinsulinemia at 20 or more weeks of age. Plasma creatinine levels were significantly higher in LRD medaka at 20 and 30 weeks of age than in control medaka ([Table 4](#tbl_004){ref-type="table"}Table 4.Plasma Creatinine Level). This suggested that, in LRD medaka, kidney function failed at 20 or more weeks of age.

No remarkable histopathological changes were observed in the kidneys of any of the six 10-week-old medaka ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Hematoxylin-eosin (HE) image of the kidney in a 10-week-old medaka. No remarkable histopathological changes are observed. Bar represents 30 µm.). The glomerular capillary lumina and the afferent/efferent arterioles were dilated in kidneys of two of the six 20-week-old medaka ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Hematoxylin-eosin (HE) image of the kidney in a 20-week-old medaka. Glomerular capillary lumina and afferent/efferent arterioles are dilated. Bar represents 30 µm.). The following histopathological changes occurred in the kidneys of four of eleven 30-week-old medaka: glomerular enlargement with mesangial cell proliferation and matrix expansion (2 of 4 fish; [Fig. 3a](#fig_003){ref-type="fig"}Fig. 3.Hematoxylin-eosin (HE) images of the kidney in a 30-week-old medaka. Glomerular enlargement with mesangial cell proliferation and matrix expansion and formation of fibrin cap-like lesions (arrowheads), and glomerular atrophy with Bowman's capsule dilation (a), glomerular atrophy with Bowman's capsule dilation and renal tubular dilation (b), and widespread renal tubular dilation (c). Bars represent 20 μm (a), 30 μm (b), or 50 μm (c).), formation of fibrin cap-like lesions (2 of 4 fish; [Fig. 3a](#fig_003){ref-type="fig"}), dilation of the glomerular capillaries ([Fig. 3b](#fig_003){ref-type="fig"}) and afferent/efferent arterioles (3 of 4 fish; [Fig. 3a](#fig_003){ref-type="fig"}), glomerular atrophy with Bowman's capsule dilation (4 of 4 fish; [Fig. 3a and b](#fig_003){ref-type="fig"}), and renal tubule dilation (4 of 4 fish; [Fig. 3c](#fig_003){ref-type="fig"}). No remarkable lesions in the tubulointerstitium, which are characteristic of chronic kidney disease (CKD) and diabetic kidney disease (DKD) model animals, were observed. Lesions were observed in both male and female animals, and the frequency of glomerular atrophy with Bowman's capsule dilation and renal tubule dilation was higher in male animals than in female animals.

In DN, the kidneys exhibit morphologic changes, from mild ischemic lesions to characteristic features of mesangial expansion, fibrin cap, mesangiolysis, and concomitant tubular basement membrane thickening, which are seen in the early phase of human DN, and ultimately exhibit global glomerulosclerosis with interstitial fibrosis and tubular atrophy^[@r32],[@r33]^. Just before developing DN, diabetic humans are in a pathophysiologic stage, a so-called silent phase, in which glomerular filtration rates (GFRs) are increased to levels approximately 50% greater than normal, but they can return to normal^[@r34]^. In the glomeruli, vascular tones of the afferent and efferent arterioles determine the hemodynamics and control the internal pressure of Bowman's capsule, and expansion of afferent/efferent arterioles increases the GFR^[@r35]^. Previous research using C57BL/6J *db*/*db* and C57BL/KsJ *db*/*db* mice demonstrated that the model mice also showed an increase in GFR with hyperglycemia^[@r36]^. Some LRD medaka at 20 or more weeks of age showed dilation of the afferent and efferent arterioles in the glomeruli. Taking into account previous reports, it was presumed that glomerular hyperfiltration occurred in LRD medaka at 20 or more weeks of age and that the afferent and efferent arterioles in the medaka may be changed due to control of the internal pressure of Bowman's capsule. Since all LRD medaka at 20 or more weeks of age showed hyperglycemia, it was thought that some medaka might be in a silent phase of DN.

In some LRD medaka at 30 weeks of age, glomerular atrophy with Bowman's capsule dilation was observed. This has been rarely described in the pathological diagnosis criteria of DN^[@r32],[@r33]^. However, glomerular atrophy with Bowman's capsule dilation was reported as a characteristic lesion in an experiment using *eNOS* (*endothelial nitric oxide synthase*) gene knockout mice^[@r37]^. It has been shown that eNOS is expressed in the renal endothelium and tubules^[@r38]^, and it has a role in protecting the kidney from ischemic injury^[@r39],[@r40]^. In 2009, Tessari *et al*. measured the activity of nitric oxide synthesis in patients with DN and reported that the patients showed lower synthesis^[@r41]^. Therefore, in some LRD medaka at 30 weeks of age, the function of eNOS might be weaker, or the kidneys might have suffered ischemic injury beyond their ability to produce eNOS.

The pathological diagnosis criteria of DN include concomitant tubular basement membrane thickening with disease progression^[@r32],[@r33]^. Although some LRD medaka at 30 weeks of age showed renal tubule dilation ([Fig. 3](#fig_003){ref-type="fig"}) and their epithelium became atrophic ([Fig. 3b and c](#fig_003){ref-type="fig"}) or disappeared ([Fig. 3a and c](#fig_003){ref-type="fig"}), there was no thickening of the basement membrane in the tubules. In various renal diseases, atubular glomeruli (AG) have been described^[@r42],[@r43]^. AG have open circulation but no tubular attachment and are presumably nonfunctioning^[@r44]^. The neighboring glomerulus shows expansion of a glomerular tuft or atrophy of the glomerular tuft with Bowman's capsule expansion^[@r45]^. AG were first reported in research involving patients with type 1 diabetes^[@r46],[@r47]^, and then characteristic lesions of AG were also identified in patients with type 2 diabetes^[@r45]^. In model mice, *eNOS* gene knockout mice showed AG with glomerular atrophy with Bowman's capsule dilation^[@r48]^. Furthermore, in *db*/*db* mice, AG notably appeared with genetic loss of function of the *eNOS* gene^[@r5],[@r49]^. Considering previous reports, it was presumed that glomeruli in some LRD medaka at 30 weeks of age would change to AG due to deterioration of *eNOS* gene function.

Albuminuria reflects widespread vascular damage and injuries to glomerular and epithelial tubular cells^[@r50],[@r51]^. In AG, epithelial cells with no brush borders, which appear to be flattened cells, were observed in some cases, whereas no epithelial cells were observed in the tubules in others^[@r47]^. The observed tubules also showed abnormal features with dilated and/or atrophic tubules. Similar tubular changes were observed in some LRD medaka at 30 weeks of age ([Fig. 3](#fig_003){ref-type="fig"}). Although it is difficult to collect urine from medaka, a higher level of plasma creatinine in LRD medaka at 30 weeks of age ([Table 4](#tbl_004){ref-type="table"}) indicated decreased renal function in the medaka. Given these data, it was possible that the fish developed albuminuria. This was suggested by the formation of fibrin cap-like lesions. In LRD medaka at 30 weeks of age, fibrin cap-like lesions were formed outside glomerular tufts ([Fig. 3a](#fig_003){ref-type="fig"}). This lesion is not a specific finding in diabetic glomerulosclerosis, and similar lesions are recognized in focal glomerulosclerosis, sclerosing glomerulus, and lupus nephritis in patients. A common pathophysiologic feature in these diseases is albuminuria, and their presence correlates with the amount of albuminuria^[@r52]^. In human DN, the fibrin cap is observed at a comparatively advanced stage^[@r32],[@r33]^. Therefore, this suggests that some LRD medaka at 30 weeks of age would develop albuminuria due to decreased renal function caused by chronic hyperglycemia, resulting in renal tubule dilation with/without epithelial cells.

Dilation of glomerular capillary lumina was recognized in LRD medaka at 20 and 30 weeks of age, and glomerular enlargement with mesangial cell proliferation and matrix expansion was observed in LRD medaka at 30 weeks of age. These are recognized from the early phase in human DN^[@r32],[@r33]^, and they are some of the most specific histological features of DN. They are also observed in many rodent models^[@r5]^. In addition, *db*/*db* mice showed decreased renal function and mesangial expansion, with a fibrin cap^[@r24]^. Streptozotocin-induced animals also showed hyperglycemia and renal function degeneration, which induced mesangial expansion and hypertrophy of glomeruli with dilation of glomerular capillary lumina^[@r53]^. Nonobese diabetic (NOD) mice also showed similar features. Studies using the NOD mouce model have supported the role of advanced glycosylation end products (AGE) in the pathogenesis of mesangial proliferation^[@r54],[@r55],[@r56],[@r57]^. Although it was presumed that dilation of glomerular capillary lumina might be caused by an increased amount of glomerular filtration, mesangial proliferation in LRD medaka at 30 weeks of age might develop because of AGE due to chronic hyperglycemia. A study using SHR (spontaneous hypertensive)/N-*cp* (*corpulent*, which is a recessive mutation in *leptin receptor* gene) rats and *cp*/*cp* rats demonstrated that the *cp*/*cp* rats showed mild glomerular changes but that the SHR/N-*cp* rats developed mesangial proliferation and albuminuria. From this study, the possibility of LRD medaka at 30 weeks of age being hypertensive could not be ruled out.

The pathological changes in DN are characterized by not only hyperglycemia and hypertension but also inflammation and infiltration of macrophages^[@r58],[@r59]^. Some reports showed that it was difficult for leptin signaling-deficient animals to show an inflammatory response^[@r60]^ because the leptin signaling pathway has a partial role in inflammation, infiltration of macrophages, and fibrogenic responses^[@r60],[@r61]^. In LRD medaka, there is loss of function of the leptin signaling pathway with no lipid abnormality^[@r28]^. Furthermore, the fish did not show an increased number of new blood vessels in the retina^[@r29]^, which is assumed to occur after the inflammatory response. Thus, we have concluded that the reason that not all hyperglycemic LRD medaka showed renal lesions would be their lack of leptin signaling.

Lack of an inflammatory response regulated by leptin signaling would provide incidental advantages. The pathogenesis of human DN is complex and remains incompletely understood. One of the major reasons for this is that the progressive pathological changes are caused by various mechanisms including inflammation, glycation, receptor for advanced glycosylation end products (RAGE) activation and hypertension, as well as others^[@r8]^. Analysis of LRD medaka would contribute to a clear understanding of the development of renal lesions independent of an inflammatory response regulated by leptin signaling. Furthermore, LRD medaka are among the animals suitable for elucidating the progressive pathological changes without surgical, pharmacological, and/or genetic modification, as well as the process in humans. LRD medaka also have a different characteristic from rodents with leptin-receptor deficiency reproductive ability. The fish are fertile with normal gonadal development in both males and females, whereas rodents with leptin-receptor deficiency exhibit delayed pubertal development and both male and female infertility^[@r23]^. Therefore, it is easier to maintain the fish than the rodents. Based on the frequency of renal lesions in LRD medaka (\>30%), 30 fish are needed to analyze 10 fish with renal lesions. This would be easily performed because the annual rearing cost of 1 medaka is lower than that of a rodent, and 8 fish can be reared in 1 rearing tank.

In conclusion, the following changes were mainly observed in LRD medaka at 20 and 30 weeks of age: dilation of the glomerular capillaries and afferent/efferent arterioles, glomerular enlargement, glomerular atrophy with Bowman's capsule dilation, and renal tubule dilation. The histopathological characteristics in the kidneys were microvascular changes induced by hyperglycemia that were similar to those in diabetic patients^[@r62],[@r63],[@r64]^ and rats^[@r65]^. Some were characteristics that meet the pathological classification criteria^[@r32],[@r33]^, and others were features of AG that have been described in various renal diseases^[@r42],[@r43]^. In the present experiment, the amount of feeding was only controlled for medaka. Therefore, it was suggested that the LRD medaka model is useful for analyzing lesions that develop with aging and feeding, and this is a novel model with lesions of DN and AG.
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